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Women with a history of gestational diabetes mellitus (GDM) are
at increased risk for developing type 2 diabetes mellitus. We ex-
amined individual, socioeconomic, and health care use character-
istics of women with a history of GDM and the association of
those characteristics with diabetes screening, and we estimated
their rates of undiagnosed prediabetes and diabetes.
Methods
Using 3 cycles of the National Health and Nutrition Examination
Survey (2007–2008, 2009–2010, and 2011–2012), we identified
284 women with a history of GDM who were eligible for diabetes
screening. Screening status was defined by self-report of having
had a  blood test  for  diabetes  within  the  prior  3  years.  Undia-
gnosed prediabetes and diabetes were assessed by hemoglobin A1c
measurement.
Results
Among women with a history of GDM, 67% reported diabetes
screening within the prior 3 years. Weighted bivariate analyses
showed screened  women differed  from unscreened  women in
measured body mass index (BMI) category (P = .01) and number
of health visits in the prior year (P = .001). In multivariable ana-
lysis, screening was associated with a greater number of health
visits  in  the prior  year  (1 visit  vs  0 visits,  adjusted odds ratio
[AOR], 1.91; 95% confidence interval [CI], 0.71–5.18; 2 or 3 vis-
its, AOR, 7.05; and ≥4 visits, AOR, 5.83). Overall, 24.4% (95%
CI, 18.3%–31.7%) of women had undiagnosed prediabetes and
6.5% (95% CI, 3.7%–11.3%) had undiagnosed diabetes.
Conclusion
More health visits in the prior year was associated with receiving
diabetes screening. Fewer opportunities for screening may delay
early detection, clinical management, and prevention of diabetes.
Prediabetes in women with a history of GDM may be underrecog-
nized and inadequately treated.
Introduction
Gestational diabetes mellitus (GDM) is defined as the onset or
first  recognition  of  diabetes  during  pregnancy,  typically  dia-
gnosed by an abnormal oral glucose tolerance test (OGTT) during
the second trimester (1,2). Prevalence of GDM ranges from 2% to
10% (3–5). Although glucose intolerance resolves immediately
after delivery in 90% of women with GDM, their risk of develop-
ing type 2 diabetes mellitus is 35% to 60% within 5 to 10 years
(6,7), which is a 5- to 7-fold increase in risk compared with wo-
men without a history of GDM. The American Diabetes Associ-
ation and American College of Obstetricians and Gynecologists
recommend diabetes screening at 6 to 12 weeks postpartum with a
2-hour, 75-g OGTT (1,2). Moreover, both organizations recom-
mend lifelong screening for diabetes at least once every 3 years
and annual screening for those with prediabetes (1,2).
Approximately 50% of women with a history of GDM obtain dia-
betes screening, with rates ranging from 30% to 70% (8). Screen-
ing with the recommended OGTT is uncommon (9); most studies
recognize or consider any marker of glucose measure as a screen-
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ing test.  A study conducted at  a  university health care system
found a screening rate of 38% with any test of glucose marker at
least 6 weeks postpartum during a 5-year period (10). Another
study found 67% of women with previous GDM had some type of
screening, but only 37% were tested with an OGTT or fasting
blood glucose within 2 years (11).
Prior studies found that postpartum diabetes screening among US
women was positively associated with women who were Asian,
had  high  levels  of  education  or  income,  were  diagnosed  with
GDM at a young age, and had a high number of health care pro-
vider contacts (12,13). However, higher parity was associated with
lower screening rates (12,13). Findings from previous US studies
have been limited to single academic centers or managed care or-
ganizations subject to local practice patterns and policies. Also,
little is known about the glycemic status and characteristics of wo-
men with GDM who disengage from the health care system after
delivery (14).
Our study objectives were to use a nationally representative data
set 1) to determine the diabetes screening rate and identify charac-
teristics associated with screening and 2) to determine the propor-
tion of women with a history of GDM with undiagnosed predia-
betes and diabetes.
Methods
Study design and oversampling
The  National  Health  and  Nutrition  Examination  Survey
(NHANES) is an ongoing cross-sectional survey of the civilian,
noninstitutionalized  US  population.  Participants  are  selected
through a complex multistage probability cluster sampling design.
Sampling methodology and data collection procedures have been
published in detail (15). Publicly released data from 3 NHANES
cycles — 2007–2008, 2009–2010, and 2011–2012 — were com-
bined  for  analysis.  Beginning  in  2007,  Hispanics  were  over-
sampled, and beginning in 2011, Asians were oversampled to im-
prove the reliability and precision of estimates for these popula-
tion subgroups. Thus, estimates of GDM prevalence among Asi-
ans were limited to the 2011–2012 cycle, and for the full analysis,
race/ethnicity was categorized as non-Hispanic white, non-Hispan-
ic black, Hispanic, and other/multiracial.
Survey components
Survey components included interviews administered at home for
all participants and a visit to the mobile examination center (MEC)
for a subsample. A standardized physical examination, laboratory
tests, and the administration of the reproductive health question-
naire to female participants aged 12 years or older via computer-
assisted personal  interview were conducted in the MEC. Data
from those aged 12 to 19 years for select reproductive health vari-
ables were excluded from public files because of disclosure con-
cerns. Hemoglobin A1c (HbA1c) level was measured, and body
mass index was calculated based on measured height and weight
for each MEC participant. Fasting glucose and OGTT were meas-
ured in a subsample of  the MEC participants  but  were not  in-
cluded in the analysis because of the small number of eligible wo-
men selected for the fasting protocol.
Variable selection
We examined the following variables: race/ethnicity, age, educa-
tion level, family income-to-poverty ratio (FIPR), marital status,
BMI, foreign-born status, language preference, age at GDM dia-
gnosis,  health insurance status, type of health insurance, place
used for routine health care, number of health care visits in prior
year, number of pregnancies, number of live births, age at first and
last birth, and having a baby with a birthweight of 9 pounds or
greater. A non-English language preference was defined for parti-
cipants who reported a non-English language spoken at least 50%
of the time at home or if a non-English language was used for any
part of the survey. Education level and FIPR were examined as
measures of socioeconomic status in the bivariate analysis. The
FIPR is calculated by dividing annual family income by poverty
guidelines specific to family size, year, and state, and is recom-
mended for comparing income data over time (15). In our analys-
is, the FIPR was categorized by the Special Supplemental Nutri-
tion Program for Women, Infants and Children (WIC) program
eligibility criteria (15). In multivariable analyses, education level
was categorized as either high school graduate or less than high
school graduate.
Cohort selection for women with a history of GDM
A  total  of  30,442  participants  were  enrolled  in  NHANES
2007–2012. Our cohort was selected from the 29,353 individuals
who attended the  MEC portion  of  the  survey (mean MEC re-
sponse rate for the 3 cycles was 74%). After excluding males and
females less than 20 years old, a total of 8,739 women were eli-
gible for the reproductive survey. Of those eligible, 6,516 repor-
ted  having  been  pregnant  or  having  had  at  least  1  pregnancy;
1,075 had missing responses. Nonresponders included those who
did not report to the MEC or did not provide an answer to the
question “Have you ever been pregnant?” Women who reported at
least 1 prior pregnancy were asked “Were you ever told by a doc-
tor or other health professional that you had diabetes, sugar dia-
betes or gestational diabetes? Please do not include diabetes that
you may have known about before the pregnancy.” Excluded from
the analysis were women who answered no (n = 5,996), “don’t
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know” (n = 12), and “borderline” (n = 75). Women who had a
positive pregnancy test at the MEC or reported a current preg-
nancy were excluded (n = 12). There were 421 women who repor-
ted a history of GDM (Figure, group A).
Figure. Flow diagram for cohort selection of women with GDM screened or
unscreened for DM, NHANES, 2007–2008, 2009–2010, and 2011–2012.
Abbreviations:  DM diabetes mellitus;  GDM, gestational  diabetes mellitus;
NHANES,  National  Health  and  Nutrition  Examination  Survey;  PreDM,
prediabetes.
 
Women with a history of GDM were considered eligible for dia-
betes screening if they did not have a self-reported diagnosis of
diabetes. Of the 421 women with a history of GDM, 128 women
reported a diagnosis of diabetes and were excluded from the ana-
lytic subsample. Women who reported a diagnosis of borderline
diabetes or prediabetes (n = 48) were included; however, those
who reported using medications to lower blood glucose (n = 7)
were excluded from the analytic subsample. Diabetes screening
status was determined by the response to “Have you had a blood
test for high blood sugar or diabetes within the past 3 years?” Wo-
men who responded “don’t know” to prior screening (n = 2) were
excluded from our analytic subsample (n = 284, Figure, group B).
Of the 284 nondiabetic, at-risk women eligible for diabetes screen-
ing, 177 reported having had a blood test for diabetes within the
prior 3 years.
Women who reported no prior diagnosis of prediabetes or border-
line diabetes but whose HbA1c was 5.7% to 6.4% (39–46 mmol/
mol) were characterized as having undiagnosed prediabetes. Wo-
men who had an HbA1c of 6.5% or higher (≥47.5 mmol/mol) were
characterized as having undiagnosed diabetes.
Statistical analysis
All  statistical  analyses used survey design variables  and were
weighted with the examination subsample MEC 6-year weight to
account for the complex sampling scheme, oversampling, and sur-
vey nonresponse to produce nationally representative estimates per
NHANES analytic guidelines (15). We generated age-adjusted
prevalence and standard errors for women with a history of GDM
(Figure, group A) with the direct method for age standardization
using 2000 US Census population data for those aged 20 years or
older, with 10-year age intervals (15). Next, we performed bivari-
ate analyses of cohort characteristics with diabetes screening. As-
sociations of categorical variables were analyzed by χ2 test of in-
dependence. Associations of normally distributed continuous vari-
ables — survey age and age at first pregnancy — were assessed by
t test. For nonnormally distributed continuous variables — age at
GDM diagnosis and age at  last  birth — a nonparametric t  test
(Wilcoxon rank sum) was used to assess the association. All tests
were 2-tailed, and P < .05 was considered significant.
We constructed multivariable logistic regression models to exam-
ine the association of diabetes screening with independent vari-
ables, adjusted for age, education, income, race/ethnicity, BMI
category, and age at GDM diagnosis. A backward elimination ap-
proach was used to fit significant independent variables to achieve
the most parsimonious model. Independent variables were evalu-
ated for collinearity by examining the variance inflation factor be-
fore inclusion in the models. We used Stata version 13.1 (Stata-
Corp LP) for all analyses. The institutional review board of the
University of Illinois at Chicago reviewed the study protocol and
determined this study exempt from human subjects research over-
sight.
Results
Prevalence of GDM in the US population
The estimated age-standardized prevalence of GDM was 7.3%
(95% confidence interval [CI], 6.3%–8.2%) for US women aged
20 or older during 2007–2012. Thirty-six percent of the women
were less than 40 years old at the time of the survey, and more
than half (56%) were obese (BMI ≥30 kg/m2). Weighted and age-
standardized (for 10-year intervals) prevalence of having had dia-
betes  diagnosed  was  24%.  Age-standardized  prevalence  was
highest among Hispanics (8.5%; 95% CI, 6.5%–10.6%), followed
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by non-Hispanic whites (6.9%; 95% CI, 5.4%–8.4%) and non-His-
panic blacks (6.6%, 95% CI, 5.4%–7.8%). Among racial/ethnic
categories, GDM prevalence was highest among women categor-
ized as other/multiracial (9.5%; 95% CI, 6.1%–12.8%). This high-
prevalence group consisted of multiracial and other race/ethnicit-
ies,  including  Asians.  Using  only  data  collected  from  the
2011–2012 cycle in which Asian race was reported and Asians
were oversampled, the age-standardized GDM prevalence among
Asians was 11.1% (95% CI, 7.4%–14.8%).
Rates of diabetes screening among women with a
history of GDM
Sixty-seven percent (95% CI, 58.9%–75.1%) of women with a
history of GDM without a diagnosis of diabetes reported blood
test screening for diabetes within the prior 3 years (weighted and
age-standardized prevalence).  A greater  number  of  visits  to  a
health  provider  in  the prior  year  was associated with diabetes
screening among women with a history of GDM (P = .002) (Table
1). Screened women differed from unscreened women by BMI
category: 53.6% versus 35.7%, respectively, were obese; 18.6%
versus 41.6% were overweight; and 27.8% versus 22.8% were un-
derweight or normal weight (P = .01).
After adjusting for age, race/ethnicity, education, FIPR, BMI cat-
egory, and age at GDM diagnosis, diabetes screening was associ-
ated with having a greater number of health provider visits in the
prior year, having a higher income (FIPR >3.5), and preferring a
language other than English or Spanish (Asian or other). The odds
of screening were higher among women who reported 2 or 3 vis-
its  (adjusted odds ratio  [AOR],  7.05;  95% CI,  2.18–22.8)  and
those reporting 4 or more visits (AOR, 5.83; 95% CI, 2.35–14.46)
compared with women who reported 0 visits (Table 2).
Rates of undiagnosed prediabetes and undiagnosed
diabetes
Fourteen  percent  (weighted  percentage)  of  women with  prior
GDM (Figure, group A) reported a diagnosis of prediabetes or
borderline diabetes. Of the 62% of women who reported normal
glycemic status (no diabetes, prediabetes, or borderline diabetes),
24.4% (95% CI, 18.3%–31.7%) had undiagnosed prediabetes and
6.5% (95% CI, 3.7%–11.3%) had undiagnosed diabetes. Overall,
one-third of the women with a history of GDM had diagnosed or
undiagnosed prediabetes. We found no differences in the propor-
tion of undiagnosed prediabetes or undiagnosed diabetes between




A greater number of health visits in the prior year was associated
with diabetes screening after adjustment for other characteristics
such as age, race/ethnicity, education, income, BMI category, and
age at GDM diagnosis. Our findings suggest unscreened women
may disengage from the health care system after delivery. Prior
qualitative studies reported a lack of time and childcare as per-
ceived practical barriers to screening, but some women also ex-
pressed fear of a diagnosis of diabetes or were uninformed of their
risk (16–18). Moreover, the recommended interval for cervical
cancer screening has lengthened to every 3 to 5 years, such that
postpartum women age 30 years or older may seek preventive
health care less frequently (19). Inadequate or lack of health care
coverage may cause some women to involuntarily disengage from
the health care system. Approximately 50% of pregnancies are
covered by Medicaid (14,20). Before Medicaid’s expansion under
the Patient Protection and Affordable Care Act, health visits more
than 60 days after pregnancy for diabetes screening and care were
not available to women in some states, which may explain the low
rate of postpartum screening observed among women with Medi-
caid (14). However, we did not find an association between type
of health insurance and screening status in our analysis.
Evidence also suggests that screening is not performed even when
women are engaged with the health care system (9,11), that is, dis-
engagement is unlikely to be a barrier to screening. Smirnakis and
colleagues showed that more than 94% of women had a Papanic-
olaou test, but only 37% underwent postpartum diabetes screen-
ing within 6 months (11). Provider unawareness of GDM diagnos-
is,  fragmentation in care,  and nonadherence to guidelines may
contribute to suboptimal screening rates (10,12,21,22). The imple-
mentation of electronic clinical support did not increase the rate of
diabetes screening (23). Only one-third of women with GDM were
referred for a screening test or given a referral to a primary physi-
cian by their obstetrician/gynecologist (24). Our findings also sug-
gest that more contact with the health care system presents more
opportunities for screening or that screening may occur in con-
junction with other provider-directed evaluations. Among those
screened, 39.6% had 4 or more health care visits in the prior year.
The rising prevalence of diabetes and obesity has contributed to a
greater awareness of these conditions among the general public
and may have prompted health providers to screen for diabetes
more often, irrespective of a GDM diagnosis. Providers consider
obesity a key risk factor for diabetes, and obese women are more
frequent users of health care services (25). We found higher rates
of obesity among screened women than among unscreened wo-
men (53% vs 35.7%). However, one-fourth of the women in the
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NHANES were underweight or normal weight, underscoring the
reality that some women may not have an obvious diabetes risk
factor.
Competing issues that may steer the agenda of the health care vis-
it toward more urgent concerns and away from preventive screen-
ing were not studied. More health encounters may offer exposure
to different providers, to different specialists, or to more opportun-
ities to address preventive care such as diabetes screening. Encour-
aging routine health care use and improving the transition from
postpartum care  to  primary care  may also contribute  to  better
screening rates.
Higher income level was also associated with screening. Women
who preferred speaking another language other than Spanish or
English were also more likely to be screened. Presumably, this
finding suggests that language may not be a uniform barrier to
screening.
Approximately one-quarter of US women with a history of GDM
had undiagnosed prediabetes, and approximately 6.5% had undia-
gnosed diabetes. None of these women were taking diabetes med-
ications and none reported a prior diagnosis of diabetes, predia-
betes, or borderline diabetes. Furthermore, the number of women
with undiagnosed prediabetes is  likely an underestimation be-
cause of the lower sensitivity of the HbA1c test. Of the women
with a history of GDM, 14% reported a diagnosis of prediabetes or
borderline diabetes, but only 8.6% reported the use of glucose-
lowering medications. In a subgroup analysis of the Diabetes Pre-
vention Program, women with a history of GDM and with predia-
betes were 48% more likely to progress to diabetes compared with
women with similar glucose intolerance without GDM (26). In
women with a history of GDM, intensive lifestyle intervention and
metformin reduced progression to diabetes by 35% and 40%, re-
spectively, compared with placebo (26). Metformin may be more
effective in prediabetic women with a history of GDM compared
with similar women without GDM (26,27).
These findings support the American Diabetes Association posi-
tion on prediabetes screening and treatment (1). Our findings show
the distribution of HbA1c  testing was not statistically different
among screened and unscreened women. Prediabetes awareness in
adults is associated with a greater likelihood of engaging in risk-
reducing behaviors (28). However, the use of metformin in the
prevention of diabetes is uncommon (29). Prediabetes in women
with a history of GDM may be underrecognized and inadequately
treated.
Early intervention offers reproductive-age women opportunities to
optimize any glucose intolerance during their interconception peri-
od, potentially decreasing subsequent diabetes-related pregnancy
complications. Delaying the onset of or preventing diabetes may
have profound and prolonged effects in the health and productiv-
ity of these women in later life (30). Therefore, women of repro-
ductive age with a history of GDM may need to be screened more
frequently. An emphasis on prediabetes screening may be con-
sidered in this high-risk population given the high risk of progres-
sion to diabetes and positive response to intervention (26). Sys-
tematic methods to improve prediabetes screening are being in-
vestigated.
Our study had numerous strengths and limitations. The use of data
from a large nationally representative sample allowed us to pro-
duce  population  estimates.  Survey  administration,  laboratory
measurements,  and  medical  examinations  were  conducted  by
highly trained personnel using standardized protocols. Survey data
was self-reported with the exception of data on weight, height, and
HbA1c. The diagnosis of GDM, history of health care usage, and
the performance of diabetes screening were not verified. Tempor-
al changes in the diagnostic criteria of GDM and standard of care
for diabetes screening in these women were not accounted for in
the  analysis;  however,  we  noted  no  significant  differences  in
screening by survey cycle. The ability to detect significant differ-
ences between screened and unscreened women may have been
limited because of our small sample size. We were unable to ex-
amine screening characteristics  of  Asians and Asian language
preference separately. However, using only data collected from the
2011–2012 cycle in which Asian race was reported and Asians
were oversampled, the age-standardized GDM prevalence among
Asians was 11.1% (95% CI, 7.4%–14.8%). This may contribute to
the high GDM prevalence noted in our other/multiracial ethnic
category.
Women with GDM reporting higher health care usage were more
likely to report diabetes screening. Limited engagement with the
health care system likely reduces opportunities for screening. An
emphasis on increasing prediabetes screening may also delay pro-
gression to diabetes and improve diabetes detection for women
with a history of GDM. Once diagnosed, efforts to promote life-
style changes and increase metformin use may help delay or pre-
vent diabetes and its complications.
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Tables
Table 1. Weighted Bivariate Analysis of Characteristics of Women With a History of Gestational Diabetes Mellitus (n = 284), by Diabetes Screening Status, NHANES,
2007–2012a
Variable Screened (n = 177) Unscreened (n = 107) P Valueb
Mean age at time of survey (SE), y 42.4 (0.9) 42.3 (1.1) .91c
Age group, % (95% CI), y
20–39 45.6 (37.5–53.8) 44.5 (35.3–54.1)
.5140–59 47.6 (38.2–57.1) 51.7 (41.9–61.4)
≥60 6.9 (3.2–14.1) 3.8 (1.6–8.8)
Mean age at GDM diagnosis (SE), y 28.1 (0.57) 27.3 (0.59) .45d
Not married,e % (95% CI) 23.0 (16.1–31.7) 25.1 (15.2–38.7) .76
Race/ethnicity, % (95% CI)
Non-Hispanic white 62.5 (51.8–72.2) 66.5 (53.2–77.5)
.08
Hispanic 14.6 (9.3–22.4) 21.1 (13.5–31.5)
Non-Hispanic black 13.6 (10.2–17.9) 6.7 (3.4–13.1)
Other/multiracialf 9.3 (5.0–16.6) 5.7 (2.5–12.5)
Not US born, % (95% CI) 21.5 (13.9–31.8) 22.4 (13.9–34.0) .88
Preferred language, % (95% CI)
English 81.9 (72.7–88.5) 83.3 (74.1–89.7)
.07Spanish 11.8 (6.9–19.4) 14.9 (8.9–24.0)
Asian or other 6.3 (2.9–13.1) 1.8 (0.7–4.3)
Education level, % (95% CI)
Less than 9th grade 4.9 (2.2–10.5) 10.4 (5.9–17.7)
.39
9th to 11th grade 12.0 (7.2–19.2) 14.2 (8.4–23.2)
High school graduate 22.0 (14.2–32.4) 25.1 (16.0–37.1)
Some college 32.5 (24.8–41.4) 32.8 (22.8–44.7)
College graduate or more 28.6 (18.8–40.9) 17.4 (9.2–30.7)
High school graduate or more, % (95% CI) 83.1 (74.5–89.2) 75.4 (66.3–82.7) .15
Family income-to-poverty ratio,g % (95% CI)
0–1.85 31.4 (23.9–40.1) 42.7 (29.7–56.8)
.21>1.85–3.5 22.6 (15.7–31.4) 26.9 (15.2–43.0)
≥3.5 46.0 (36.0–56.2) 30.4 (18.8–45.3)
Health insurance, % (95% CI) 80.5 (72.3–86.7) 71.3 (61.4–79.5) .13
Insurance coverage type, % (95% CI)




; NHANES, National Health and Nutrition Examina-
tion and Survey; SE, standard error.
a All percentages are weighted.
b χ2 test of independence unless otherwise noted.
c Unpaired 2-tailed t test; degrees of freedom = 49 for mean age at time of survey, 48 for mean age at first birth.
d Wilcoxon rank sum test.
e Single, separated, or divorced.
f Beginning in 2011, Asians were oversampled to improve the reliability and precision of estimates for these population subgroups.
g Based on eligibility categories for Special Supplemental Nutrition Program for Women, Infants and Children (15).
(continued on next page)
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(continued)
Table 1. Weighted Bivariate Analysis of Characteristics of Women With a History of Gestational Diabetes Mellitus (n = 284), by Diabetes Screening Status, NHANES,
2007–2012a
Variable Screened (n = 177) Unscreened (n = 107) P Valueb
Private 63.7 (54.5–72.1) 57.4 (45.8–68.2)
.31
Medicaid 7.1 (4.7–10.5) 4.7 (2.3–9.2)
Medicare/Medigap 2.5 (1.1–5.6) 4.0 (1.7–9.2)
Other 7.2 (3.7–13.5) 5.3 (2.5–10.8)
No coverage 19.5 (13.3–27.8) 28.7 (20.6–38.6)
Have a place for routine health care, % (95% CI) 88.3 (80.5–93.3) 78.5 (66.4–87.1) .12
Place often used for routine health care, % (95% CI)
Clinic or health center 18.9 (13.4–25.9) 20.9 (13.5–30.8)
.24
Office or health maintenance organization 64.9 (56.3–72.6) 55.3 (42.7–67.2)
Other (emergency department, hospital, urgent care) 4.6 (1.9–10.6) 2.4 (0.79–7.1)
None 11.7 (6.7–19.5) 21.5 (12.9–33.6)
No. of health care visits in prior year, % (95% CI)
None 9.3 (5.2–16.1) 24.2 (14.9–36.8)
.002
1 14.6 (8.8–23.3) 30.7 (19.5–44.8)
2 or 3 36.5 (29.0–44.7) 20.5 (12.2–32.4)
≥4 39.6 (31.7–48.1) 24.6 (17.0–34.2)
No. of pregnancies, % (95% CI)
1 12.8 (7.1–22.0) 10.6 (4.6–22.5)
.93
2 25.2 (16.9–35.9) 25.5 (15.7–38.6)
3 26.4 (18.9–35.5) 24.5 (16.9–34.3)
>4 35.6 (27.8–44.3) 39.3 (29.1–50.6)
No. of live births, % (95% CI)
0 0.3 (0.0–2.2) 0
.51
1 24.3 (15.9–35.3) 16.7 (8.2–31.0)
2 39.6 (28.4–52.0) 38.9 (27.8–51.1)
3 22.4 (16.3–30.0) 30.5 (27.8–51.1)
≥4 13.4 (9.0–19.5) 14.0 (8.5–22.0)
Mean age at first birth (SE), y 23.1 (0.6) 23.2 (0.6) .91c
Mean age at last birth, y (SE) 30.4 (0.5) 30.1 (0.6) .74d
Had baby with birthweight ≥9 pounds, % (95% CI) 29.9 (20.4–41.4) 30.6 (18.8–45.7) .93
BMI (kg/m2), % (95% CI)




; NHANES, National Health and Nutrition Examina-
tion and Survey; SE, standard error.
a All percentages are weighted.
b χ2 test of independence unless otherwise noted.
c Unpaired 2-tailed t test; degrees of freedom = 49 for mean age at time of survey, 48 for mean age at first birth.
d Wilcoxon rank sum test.
e Single, separated, or divorced.
f Beginning in 2011, Asians were oversampled to improve the reliability and precision of estimates for these population subgroups.
g Based on eligibility categories for Special Supplemental Nutrition Program for Women, Infants and Children (15).
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(continued)
Table 1. Weighted Bivariate Analysis of Characteristics of Women With a History of Gestational Diabetes Mellitus (n = 284), by Diabetes Screening Status, NHANES,
2007–2012a
Variable Screened (n = 177) Unscreened (n = 107) P Valueb
<25.0 (Underweight or normal weight) 27.8 (20.5–36.4) 22.8 (13.6–35.6)
.0125.0–29.9 (Overweight) 18.6 (11.9–27.9) 41.6 (30.6–53.4)
≥30.0 (Obese) 53.6 (44.2–62.8) 35.7 (25.7–47.1)
HbA
1c,
 % (95% CI)
<5.7 (<39 mmol/mol) 68.6 (59.2–76.8) 67.7 (56.1–77.4)
.965.7–6.4 (39–46 mmol/mol) 24.2 (17.0–33.1) 25.8 (16.2–38.5)
≥6.5 (≥47.5 mmol/mol) (Undiagnosed diabetes) 7.2 (3.5–14.0) 6.5 (2.9–13.9)
Undiagnosed prediabetes, % (95% CI) 22.4 (15.6–31.0) 25.8 (16.2–38.5) .59




; NHANES, National Health and Nutrition Examina-
tion and Survey; SE, standard error.
a All percentages are weighted.
b χ2 test of independence unless otherwise noted.
c Unpaired 2-tailed t test; degrees of freedom = 49 for mean age at time of survey, 48 for mean age at first birth.
d Wilcoxon rank sum test.
e Single, separated, or divorced.
f Beginning in 2011, Asians were oversampled to improve the reliability and precision of estimates for these population subgroups.
g Based on eligibility categories for Special Supplemental Nutrition Program for Women, Infants and Children (15).
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Table 2. Multivariable Logistic Regression Model Examining the Association Between Diabetes Screening and Selected Independent Variables, NHANES,
2007–2012
Independent Variable AOR (95% CI) P Value
Age at time of survey 0.98 (0.95–1.01) .12
Age at GDM diagnosis 1.04 (0.99–1.10) .10
Race/ethnicity
Non-Hispanic white 1 [Reference]
Hispanic 0.50 (0.13–1.86) .29
Non-Hispanic black 1.93 (0.81–4.62) .14
Other/multiraciala 0.61 (0.17–2.18) .44
High school graduate 1.17 (0.61–2.24) .63
Family income-to-poverty ratiob
0–1.85 1 [Reference]
>1.85–3.5 1.46 (0.58–3.57) .43
>3.5 2.49 (1.07–5.78) .03
BMI (kg/m2)
<25.0 1 [Reference]
25.0–29.9 0.58 (0.22–1.53) .26
≥30.0 1.63 (0.69–3.85) .26
Preferred language
English 1 [Reference]
Spanish 3.34 (0.66–16.85) .14
Asian or other 8.93 (1.55–51.44) .02
No. of health care visits in prior year
None 1 [Reference]
1 1.91 (0.71–5.18) .20
2 or 3 7.05 (2.18–22.8) .002
≥4 5.83 (2.35–14.46) <.001
Abbreviations: AOR, adjusted odds ratio; BMI, body mass index; CI, confidential interval; GDM, gestational diabetes mellitus; NHANES, National Health and Nutri-
tion Examination and Survey.
a Beginning in 2011, Asians were oversampled to improve the reliability and precision of estimates for these population subgroups.
b Based on eligibility categories for Special Supplemental Nutrition Program for Women, Infants and Children (15).
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